Fampridine [Design Issues]

posted by MaggieSantos – Portugal, 2017-09-20 15:05 (2404 d 00:17 ago) – Posting: # 17821
Views: 4,613

Good morning,

We have been asked to perform a BE study on Fampridine.

I would like to confirm two informations. Does Fampridine is considered a NTI drug for EMA?

Considering a CI limit of 90-111% whats the recomende sample size for fampridine.

Do you know any good and free calculation site for BE?

Kind Regards

mMrgarida Barreto

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,655 registered users;
103 visitors (0 registered, 103 guests [including 4 identified bots]).
Forum time: 15:23 CEST (Europe/Vienna)

The whole purpose of education is
to turn mirrors into windows.    Sydney J. Harris

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5